Your browser doesn't support javascript.
loading
Inhibitory effects of temozolomide on glioma cells is sensitized by RSL3-induced ferroptosis but negatively correlated with expression of ferritin heavy chain 1 and ferritin light chain.
Yang, Fei-Cheng; Wang, Chuan; Zhu, Jiang; Gai, Qu-Jing; Mao, Min; He, Jiang; Qin, Yan; Yao, Xiao-Xue; Wang, Yan-Xia; Lu, Hui-Min; Cao, Mian-Fu; He, Ming-Min; Wen, Xian-Mei; Leng, Ping; Cai, Xiong-Wei; Yao, Xiao-Hong; Bian, Xiu-Wu; Wang, Yan.
Afiliação
  • Yang FC; Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Army Medical University (Third Military Medical University), Chongqing, China.
  • Wang C; Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Army Medical University (Third Military Medical University), Chongqing, China.
  • Zhu J; Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Army Medical University (Third Military Medical University), Chongqing, China.
  • Gai QJ; Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Army Medical University (Third Military Medical University), Chongqing, China.
  • Mao M; Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Army Medical University (Third Military Medical University), Chongqing, China.
  • He J; Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Army Medical University (Third Military Medical University), Chongqing, China.
  • Qin Y; Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Army Medical University (Third Military Medical University), Chongqing, China.
  • Yao XX; Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Army Medical University (Third Military Medical University), Chongqing, China.
  • Wang YX; Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Army Medical University (Third Military Medical University), Chongqing, China.
  • Lu HM; Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Army Medical University (Third Military Medical University), Chongqing, China.
  • Cao MF; Biobank of Institute of Pathology, Southwest Hospital, Army Medical University (Third Military Medical University), Chongqing, China.
  • He MM; Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Army Medical University (Third Military Medical University), Chongqing, China.
  • Wen XM; Department of Obstetrics and Gynecology, Southwest Hospital, Army Medical University (Third Military Medical University), Chongqing, China.
  • Leng P; Department of Pathology, General Hospital of Central Theater Command of PLA, Wuhan, China.
  • Cai XW; Department of Pharmacy, the Affiliated Hospital of Qingdao University, Qingdao, China.
  • Yao XH; Department of Obstetrics and Gynecology, Southwest Hospital, Army Medical University (Third Military Medical University), Chongqing, China.
  • Bian XW; Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Army Medical University (Third Military Medical University), Chongqing, China.
  • Wang Y; Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Army Medical University (Third Military Medical University), Chongqing, China.
Lab Invest ; 102(7): 741-752, 2022 07.
Article em En | MEDLINE | ID: mdl-35351965

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Glioblastoma / Ferroptose / Glioma Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Lab Invest Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Glioblastoma / Ferroptose / Glioma Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Lab Invest Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China País de publicação: Estados Unidos